Related Experiment Video
Updated: Aug 15, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Treating hyperlipidemia in African Americans
L M Prisant1, C Thurmond, V J Robinson
1Medical College of Georgia, Augusta, Georgia 30912-3105, USA. mprisant@mail.mcg.edu
Insights
African Americans have similar hypercholesterolemia rates but less awareness and fewer pharmacological studies. More research is needed to understand hyperlipidemia
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Hypercholesterolemia affects Black and White populations similarly, yet Black individuals are underrepresented in pharmacological research.
- Intimal atherosclerotic involvement is observed in young males of both racial groups.
- Epidemiological data indicate a higher mortality rate from coronary disease in Black versus White populations in the U.S.
Purpose of the Study:
- To provide information on hyperlipidemia treatment specifically for African Americans.
- To highlight the disparity in research and awareness of hypercholesterolemia within this demographic.
Main Methods:
- Review of epidemiological studies on hyperlipidemia prevalence and outcomes in African Americans.
- Examination of existing pharmacological studies, noting the underrepresentation of Black participants.
- Discussion of ongoing trials like the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Main Results:
- Thirty-four percent of African Americans require a fasting lipid profile, and 9% need lipid-lowering therapy.
- Awareness of hypercholesterolemia is significantly lower in Black individuals (26%) compared to White individuals (47%).
- Statins like lovastatin and pravastatin have demonstrated efficacy in treating hypercholesterolemia.
Conclusions:
- Despite similar prevalence, African Americans face unique challenges in hyperlipidemia management, including lower awareness and research neglect.
- Further randomized, blinded, prospective trials are essential to evaluate hyperlipidemia's impact and the benefits of its reduction in African Americans.
Abstract:
The purpose of this paper is to provide information concerning the treatment of hyperlipidemia in African Americans. There is a similar prevalence of hypercholesterolemia in Blacks and Whites, but Blacks have been neglected in most pharmacological studies of hyperlipidemia. Intimal atherosclerotic involvement of the aorta and coronary artery occurs in young Black and White males. Epidemiological studies suggest there is a higher mortality rate due to coronary disease in Blacks vs Whites in the United States. Thirty-four percent of Blacks require a fasting lipid profile and 9% of Black adults aged 20 years or older would require lipid-lowering therapy. However, fewer Blacks (26%) than Whites (47%) are aware of their hypercholesterolemia. Studies with lovastatin and pravastatin show efficacy in the treatment of hypercholesterolemia. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is designed to determine all-cause mortality for subjects receiving pravastatin vs a control group receiving "usual care." Randomized, blinded, prospective trials are needed to assess the impact of hyperlipidemia as a risk factor, and the impact of its reduction in African Americans.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management

